<VariationArchive RecordType="classified" VariationID="11395" VariationName="NM_000061.3(BTK):c.642_643del (p.Ser214fs)" VariationType="Deletion" Accession="VCV000011395" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2018-11-03" MostRecentSubmission="2018-11-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26434" VariationID="11395">
      <GeneList>
        <Gene Symbol="BTK" FullName="Bruton tyrosine kinase" GeneID="695" HGNC_ID="HGNC:1133" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="101349450" stop="101390796" display_start="101349450" display_stop="101390796" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="100604434" stop="100641211" display_start="100604434" display_stop="100641211" Strand="-" />
          </Location>
          <OMIM>300300</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BTK">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BTK">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000061.3(BTK):c.642_643del (p.Ser214fs)</Name>
      <CanonicalSPDI>NC_000023.11:101360700:CAC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="101360701" stop="101360702" display_start="101360701" display_stop="101360702" variantLength="2" positionVCF="101360700" referenceAlleleVCF="TCA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="100615689" stop="100615690" display_start="100615689" display_stop="100615690" variantLength="2" positionVCF="100615688" referenceAlleleVCF="TCA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>S214fs</ProteinChange>
      <ProteinChange>S248fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000061.2" sequenceAccession="NM_000061" sequenceVersion="2" change="c.642_643delTG">
            <Expression>NM_000061.2:c.642_643delTG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.100615690_100615691del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.100615690_100615691del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.101360702_101360703del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.101360702_101360703del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009616.1" sequenceAccession="NG_009616" sequenceVersion="1" change="g.30523_30524del">
            <Expression>NG_009616.1:g.30523_30524del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000061.3" sequenceAccession="NM_000061" sequenceVersion="3" change="c.642_643del" MANESelect="true">
            <Expression>NM_000061.3:c.642_643del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000052.1" sequenceAccession="NP_000052" sequenceVersion="1" change="p.Ser214fs">
            <Expression>NP_000052.1:p.Ser214fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287344.2" sequenceAccession="NM_001287344" sequenceVersion="2" change="c.744_745del">
            <Expression>NM_001287344.2:c.744_745del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274273.1" sequenceAccession="NP_001274273" sequenceVersion="1" change="p.Ser248fs">
            <Expression>NP_001274273.1:p.Ser248fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287345.2" sequenceAccession="NM_001287345" sequenceVersion="2" change="c.642_643del">
            <Expression>NM_001287345.2:c.642_643del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274274.1" sequenceAccession="NP_001274274" sequenceVersion="1" change="p.Ser214fs">
            <Expression>NP_001274274.1:p.Ser214fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_128" sequenceAccession="LRG_128">
            <Expression>LRG_128:g.30523_30524del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300300.0054" DB="OMIM" />
        <XRef Type="rs" ID="1569292818" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000061.3(BTK):c.642_643del (p.Ser214fs) AND X-linked agammaglobulinemia" Accession="RCV000012148" Version="12">
        <ClassifiedConditionList TraitSetID="3110">
          <ClassifiedCondition DB="MedGen" ID="C0221026">X-linked agammaglobulinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-10-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-10-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-11-03" MostRecentSubmission="2018-11-03">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11586956</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3110" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="39" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked agammaglobulinemia</ElementValue>
                <XRef ID="X-linked+agammaglobulinemia/7543" DB="Genetic Alliance" />
                <XRef ID="65880007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agammaglobulinemia, Bruton tyrosine kinase</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agammaglobulinemia, BTK</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BTK-deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY 1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bruton-type agammaglobulinemia</ElementValue>
                <XRef ID="MONDO:0010421" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bruton's agammaglobulinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XLA</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AGMX1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1033" />
                <XRef ID="1033" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">X-linked agammaglobulinemia (XLA) is characterized by recurrent bacterial infections in affected males in the first two years of life. Recurrent otitis is the most common infection prior to diagnosis. Conjunctivitis, sinopulmonary infections, diarrhea, and skin infections are also frequently seen. Approximately 60% of individuals with XLA are recognized as having immunodeficiency when they develop a severe, life-threatening infection such as pneumonia, empyema, meningitis, sepsis, cellulitis, or septic arthritis. S pneumoniae and H influenzae are the most common organisms found prior to diagnosis and may continue to cause sinusitis and otitis after diagnosis and the initiation of gammaglobulin substitution therapy. Severe, difficult-to-treat enteroviral infections (often manifest as dermatomyositis or chronic meningoencephalitis) can be prevented by this treatment. The prognosis for individuals with XLA has improved markedly in the last 25 years as a result of earlier diagnosis, the development of preparations of gammaglobulin that allow normal concentrations of serum IgG to be achieved, and more liberal use of antibiotics.</Attribute>
                <XRef ID="NBK1453" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301626</ID>
                <ID Source="BookShelf">NBK1453</ID>
              </Citation>
              <XRef ID="229717" DB="Orphanet" />
              <XRef ID="47" DB="Orphanet" />
              <XRef ID="C0221026" DB="MedGen" />
              <XRef ID="MONDO:0010421" DB="MONDO" />
              <XRef Type="MIM" ID="300755" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32382" SubmissionDate="2018-10-29" DateLastUpdated="2018-11-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300300.0054_AGAMMAGLOBULINEMIA, X-LINKED" title="BTK, 2-BP DEL, 54TG_AGAMMAGLOBULINEMIA, X-LINKED" />
        <ClinVarAccession Accession="SCV000032382" DateUpdated="2018-11-03" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-10-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with X-linked agammaglobulinemia (XLA; 300755) who developed classic type I diabetes at the age of 14 years, Martin et al. (2001) identified a 2-bp deletion (TG) at nucleotides 54-55 in exon 8 of the BTK gene, resulting in a frameshift at codon 214 in the TH domain and a premature stop codon at position 223 in the SH3 domain of the BTK protein.</Attribute>
              <Citation>
                <ID Source="PubMed">11586956</ID>
              </Citation>
              <XRef DB="OMIM" ID="300755" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BTK" />
          </GeneList>
          <Name>BTK, 2-BP DEL, 54TG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 54TG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300300.0054" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AGAMMAGLOBULINEMIA, X-LINKED</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32382" TraitType="Disease" MappingType="Name" MappingValue="AGAMMAGLOBULINEMIA, X-LINKED" MappingRef="Preferred">
        <MedGen CUI="C0221026" Name="X-linked agammaglobulinemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

